Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Nelson, Collins to fill void left by Lander at White House

Plus Clayton joins Horizon as EVP, general counsel and updates from Ribon, Leo and more

February 18, 2022 2:14 AM UTC

U.S. President Joe Biden picked Alondra Nelson to replace Eric Lander as director of the White House Office of Science and Technology Policy (OSTP) and former NIH Director Francis Collins to be his acting science adviser and co-chair of the President’s Council of Advisors on Science and Technology until permanent leadership is nominated and confirmed. Nelson has been serving as OSTP’s deputy director for science and society. Last week, Lander resigned as OSTP director amid allegations of creating a toxic work environment.

Ribon Therapeutics Inc. hired Prakash Raman as president, CEO and a board member. Raman succeeds Victoria Richon, who will become an R&D adviser and chair of the company’s scientific advisory board. Raman was a senior partner and chief business development officer at Flagship Pioneering and VP, global head of Novartis Institutes for Biomedical Research business development and licensing at Novartis AG (SIX:NOVN; NYSE:NVS). Ribon is developing small molecule inhibitors of NAD+-utilizing enzymes. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article